Harnessing the Power of AI & Data
TECHNOLOGY, VIDEO

Harnessing the Power of AI & Data

As AT&T’s Chief Data Officer, Andy Markus leads the vision for data platforms and analytics to position AT&T for growth and serving customers in new ways. His Chief Data Office (CDO) is building enterprise-wide target architecture and solutions for the company. CDO will transform and modernize AT&T data platforms, data supply chain and the data science ecosystem. These initiatives, along with a cutting-edge AI and automation framework, will significantly enhance revenue and reduce costs, while driving a special responsibility to champion data governance creating a unified enterprise view of AT&T data assets using a federated approach to data.

Continue reading
Driving a Digital Enterprise – A Strategic Mindset Shift
TECHNOLOGY, VIDEO

Driving a Digital Enterprise – A Strategic Mindset Shift

Dalia Powers is a technology executive focused on transforming organizations in Digital, Analytics, Data and core technology. Sets strategy, and drives results across industries including creating innovative digital products powered by AI/ML that reimagine customer experiences. She is experienced in leading global organizations of ~1,800 resources and ~$307M annual budget. An authentic and trusted leader who is passionate about developing and empowering the next generation of executives, Dalia is recognized for accelerating Agile Transformation, Cloud adoption, encouraging innovation, improving delivery and enhancing quality. Energetic leader with a broad perspective and deep technical roots.

Continue reading
The Future of Decisions. Now.
TECHNOLOGY, VIDEO

The Future of Decisions. Now.

As the Chief Customer Officer at Aera Technology, Laurent Lefouet leads the company’s high-performing customer success initiatives and operations. A strategic, outcome-focused leader, Laurent puts customers at the center of the experience to deliver satisfaction, retention, and growth. He brings more than 25 years of experience in enterprise software and technology. Prior to Aera, Laurent served as the Managing Director for EMEA at Anaplan. Before Anaplan, he was the Chief Operating Officer and Vice President of Large Enterprise Sales for SAP France. Laurent has also held international management roles at Business Objects Global and SAP EMEA and India.

Continue reading
Four Tough Questions About Your Software You are Afraid to Ask
TECHNOLOGY, VIDEO

Four Tough Questions About Your Software You are Afraid to Ask

As Vice President of Product for CAST Highlight, Greg leads strategy for CAST’s SaaS product helping clients and partners govern application portfolios, accelerate application modernization, control open source risks, and make greener software. He has held technology leadership roles with Fortune 500 companies such as Microsoft, IDG, and Arrow Electronics for over 20 years. Greg has a B.S. in Electrical Engineering and an M.S. in Management of Technology and is passionate about applying technology to improve business and our everyday lives.

Continue reading
How the Global Pandemic Changed Information Technology Forever — A Conversation with Gregory S. Smith
PODCAST, TECHNOLOGY

How the Global Pandemic Changed Information Technology Forever — A Conversation with Gregory S. Smith

Gregory S. Smith is the CIO of the American Kidney Fund, a professor at Georgetown University, and the author of five books, the most recent of which is The New Normal in IT: How the Global Pandemic Changed Information Technology Forever. In this interview we talk about his new book and his thoughts on the pandemic and post-pandemic business landscape. Did COVID-19 accelerate trends that were already in the process of becoming the new normal, or was a worldwide disruption of this magnitude necessary to transform our working lives? How has technology allowed us to weather this crisis, and what have we learned from the experience that will inform our future business decisions? Is hybrid and remote work here to stay? How does that inform the ongoing conversations about attracting and retaining top talent?

We also speak about Executive Platforms’ upcoming new series, the North American Technology Executive Summit, and some of the big ideas and key themes that will be included in its agenda. What should CIOs and CTOs be working on right now to position their organizations best for a future whose ‘New Normal’ is still being defined?

Continue reading
Operational Excellence, Innovation & Teamwork as Enablers for Reimagining Medicine
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Operational Excellence, Innovation & Teamwork as Enablers for Reimagining Medicine

As President, Operations, Steffen Lang leads a team of 35,000 associates dedicated to manufacturing and supplying high-quality medicines to patients, and providing operational support to the entire Novartis enterprise. Novartis Operations incorporates the company’s manufacturing, quality, and supply organization, as well as information technology, data and digital, procurement, environmental sustainability, facility services, and other global services.

Prior to taking on this role, Steffen was Global Head of Novartis Technical Operations (NTO). Under his leadership, NTO underwent a transformation to become one of the leading manufacturing and supply organizations in the industry, providing agile, efficient support to the business, and reliably delivering life-changing medicines to patients around the world. During this time, the unit adapted its manufacturing capacity and capabilities to the changing needs of the Novartis strategy and product portfolio, maximizing the potential of its assets and expertise. As well as delivering technological innovation to enable the production of advanced therapeutic platforms, the unit collaborated with industry partners to support global demand for COVID-19 vaccines and therapies.

Continue reading
Our Journey in Next Generation Manufacturing: What We Can Achieve Together
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Our Journey in Next Generation Manufacturing: What We Can Achieve Together

Jim Cafone has been with Pifzer since 2010.  In his current role as Senior Vice President, Global Supply Chain, Jim oversees global demand forecasting, demand and supply planning, worldwide logistics, and inventory management for Pfizer.

In his previous role, as Vice President, Network Design & Performance, Jim was responsible for business development, supply chain network design, Pfizer’s lean production system, all performance reporting and analytics, innovation, and recognition programs.

Continue reading
Quality and Compliance from the Regulators’ Perspective
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Quality and Compliance from the Regulators’ Perspective

Peter Marks received his graduate degree in cell and molecular biology and his medical degree at New York University and completed Internal Medicine residency and Hematology/Medical Oncology training at Brigham and Women’s Hospital in Boston. He has worked in academic settings teaching and caring for patients and in industry on drug development. He joined the FDA in 2012 as Deputy Center Director for CBER and became Center Director in January 2016.

Continue reading
Panel: ‘Next’ Generation Manufacturing: What Did We Learn and Where Are We Going?
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Panel: ‘Next’ Generation Manufacturing: What Did We Learn and Where Are We Going?

At PMWS23 we recorded a panel on ‘Next’ Generation Manufacturing that looks at where the industry has come from, and where it’s going in the future.

From discussing how today’s pipeline and technologies are reshaping biomanufacturing, to looking at the technologies that enable next generation manufacturing processes, give this one a listen!

Continue reading
Leading Through Transformations and Integrations – The Evolution of Global Product Development and Supply
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Leading Through Transformations and Integrations – The Evolution of Global Product Development and Supply

Karin Shanahan oversees worldwide product development, manufacturing and supply for Bristol Myers Squibb as executive vice president, Global Product Development & Supply (GPS). GPS develops and produces active ingredients and drug products and delivers the company’s medicines throughout the world. The GPS team achieves this mission through a relentless focus on innovation, quality, safety and agility.

“I’m excited to return to Bristol Myers Squibb, where I began my career in the pharmaceutical industry. Though I’ve worn many hats in the industry since then, I was drawn back to Bristol Myers Squibb because of its unwavering dedication to quality and delivering innovative medicines to patients in need,” says Karin. “I am honored to help lead the integral GPS team as we navigate an everchanging landscape.”

Continue reading
Fireside Chat: The New Normal and Beyond: How to Design the Fit for Purpose Technical Operations Organization of the Future
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Fireside Chat: The New Normal and Beyond: How to Design the Fit for Purpose Technical Operations Organization of the Future

An international operations executive with global technical, operational, and P&L experience, Carlo has deep expertise in designing and operating global supply chains in complex regulatory environments, leading accretive M&A activity and devising and executing value-creating strategies in global markets.

Since May 2020, Carlo has been the lead advisor for Manufacturing and Supply Chain to Operation Warp Speed/Federal Covid Response, the US government initiative to support the acceleration of development and supply of Covid-19 vaccines and therapeutics. He has collaborated with the sponsors, suppliers and CDMOs to ensure the fast scale-up of manufacturing and distribution for the entire US.

Continue reading
Managing Innovation and Variability in a Growth Environment
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Managing Innovation and Variability in a Growth Environment

Andrew (Andy) Wirths is a senior pharmaceutical operations leader with over 30 years’ experience in the industry spanning small and large molecule manufacturing.

Andy joined AstraZeneca in 2015 and is currently Senior Vice President, Americas Supply, where he is responsible for overseeing the manufacturing operations of 8 sites in North and South America.

Previously Andy held various senior positions at Merck where he was fundamental to the development of their manufacturing strategy and its execution at multiple sites.

Continue reading
Fireside Chat: The Emerging Role of the CDMO in Commercialization of Advanced Therapeutics
LIFE SCIENCES

Fireside Chat: The Emerging Role of the CDMO in Commercialization of Advanced Therapeutics

Spencer has more than 30 years of experience in Manufacturing and CMC product development. While at Rubius, Spencer built the technical functions to design and deliver the RED™M manufacturing platform, including clearance of 4 IND’s over 4 years.

He also led the acquisition and re-fit of their Red Cell Therapeutics manufacturing site in Smithfield Rhode Island, where the team transferred and delivered clinical supplies for their 3 oncology programs. Prior to joining Rubius, Spencer served as VP & Global Head of Cell & Gene Technical Development and Manufacturing at Novartis where he led the CMC development and manufacturing organization to deliver the CAR-T portfolio. Under his leadership, the team successfully registered and launched the first CAR-T cellular therapy product, Kymriah, which has demonstrated transformative efficacy in patients with acute lymphoblastic leukemia. While at Novartis, Spencer also led technical development teams across the Novartis Biologics portfolio in support of the commercialization of Cosentyx® and the registration and approval of Erelzi™M? and Rixathon®.

Continue reading
Transforming a Global Development & Product Supply Network for Delivering a Multi-Modal Portfolio – It’s More than Flexible Facilities
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Transforming a Global Development & Product Supply Network for Delivering a Multi-Modal Portfolio – It’s More than Flexible Facilities

Dr. Jens Vogel rejoined Bayer in March of 2020 as Global Head of Biotech for the Bayer Pharmaceuticals Product Supply organization. He has more than 20 years of professional and leadership experience in the area of biologics operations, development and technology management. From 2012 until 2020, he held positions of increasing responsibility at Boehringer Ingelheim (BI), including as President and CEO of BI Fremont Inc and member of BI’s Biopharma Executive Committee. Prior to his years at BI, Dr. Vogel was a member of the Biologics Development Leadership team at Bayer in Berkeley. Jens holds a PhD in Biotechnology from University of Braunschweig, Institute of Technology, Germany.

Continue reading